Gilead was hit badly in last few sessions, due to risk aversion mood on global markets. Biotech is often the first sector to suffer in such times... If we suggest that there is a falling channel on daily chart, its lower border is already close, and after 1-2 more sessions a bounce might be likely $GILD, Gilead Sciences, Inc. / 1440